Cytosorbents
CTSO
#9868
Rank
NZ$73.6 M
Marketcap
NZ$1.17
Share price
6.74%
Change (1 day)
-21.15%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -NZ$22.55 Million

According to Cytosorbents's latest financial reports the company's current earnings are NZ$36.97 Million. In 2024 the company made an earning of -NZ$39.19 Million, an increase over its 2023 earnings that were of -NZ$50.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$22.55 Million-42.45%
2024 -NZ$39.19 Million-22.49%
2023 -NZ$50.56 Million-13.52%
2022 -NZ$58.47 Million34.04%
2021 -NZ$43.62 Million182.17%
2020 -NZ$15.46 Million-55.97%
2019 -NZ$35.11 Million14.17%
2018 -NZ$30.75 Million95.14%
2017 -NZ$15.76 Million-22.32%
2016 -NZ$20.29 Million39.1%
2015 -NZ$14.59 Million-12.89%
2014 -NZ$16.74 Million89%
2013 -NZ$8.86 Million26.65%
2012 -NZ$7 Million-26.02%
2011 -NZ$9.46 Million-288.45%
2010 NZ$5.01 M-4.17%
2009 NZ$5.23 M-287.19%
2008 -NZ$2.8 Million-47.12%
2007 -NZ$5.29 Million41.78%
2006 -NZ$3.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
NZ$95.7 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$1.37 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$5.63 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA